Industry News
Researchers Discover How Breast Cancer Spreads
May 08, 2013
Researchers at Washington University School of Medicine in St. Louis have discovered why breast cancer patients with dense breasts are more likely than others to develop aggressive tumors that spread. The finding opens the door to drug treatments that prevent metastasis. It has long been known that women with denser breasts are at higher risk for breast cancer... Read More
Better Outcomes In Anemic Surgical Patients With Fewer Transfusion-Related Complications With Single, High-Dose Erythropoietin
May 08, 2013
Anemia increases operative mortality and morbidity in non-cardiac and cardiac surgical procedures. Anemic surgical patients may require more blood transfusions, raising the risk of transfusion-related complications and increasing costs. For those reasons, optimizing patient readiness by correcting anemia prior to surgery is an important clinical goal... Read More
Nerve Protecting Agents May Help Prevent Chemotherapy-Induced Anemia
May 08, 2013
Cancer chemotherapy can cause peripheral neuropathy - nerve damage often resulting in pain and muscle weakness in the arms and legs. Now, researchers at Albert Einstein College of Medicine of Yeshiva University have discovered that chemo also induces an insidious type of nerve damage inside bone marrow that can cause delays in recovery after bone marrow transplantation... Read More
CT Screening Reduces Lung Cancer Deaths
May 07, 2013
CT (computed tomography) screening can reduce lung cancer deaths among high-risk individuals, according to results from the National Lung Cancer Study... Read More
Weekend Visits To ER May Lead To Greater Risk Of Mortality For Some Prostate Cancer Patients
May 07, 2013
Patients with prostate cancer that has metastasized, or spread, to other parts of the body face a significantly higher risk of dying when visiting a hospital emergency department on the weekend instead of on a weekday, according to researchers at Henry Ford Hospital in Detroit... Read More
Novel Therapeutic Approach To Treating Inflammation In Cardiovascular Disease
May 07, 2013
Peptide receptor radionuclide therapy (PRRT) with radiolabeled somatostatin analogs, an established treatment for cancer patients, could offer a novel therapeutic approach to decrease levels of inflammation in the atherosclerotic plaques of patients with cardiovascular disease (CVD), reported an abstract¹ study at the International Conference on Nuclear Cardiology and Cardiac ... Read More
Identification Of Inhibitors Of Human Proteins That Promote Tumor Formation May Lead To Novel Anti-Cancer Therapeutics
May 07, 2013
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside. Understanding and being able to control these alterations could lead to new approaches for activating or inactivating genes linked to cancer... Read More
Tanning Bed Risks - FDA Aims To Increase Consumer Awareness
May 07, 2013
The U.S. Food and Drug Administration (FDA) wants to reclassify sunlamp products so that their labeling includes a recommendation against young people using them. For the moment, the FDA move is just a proposed order that it aims to eventually finalize... Read More
The Energy Landscape Of Ion Channels Revealed By Computer Simulations
May 07, 2013
Ion channels are important drug targets. A young team of researchers led by pharmacologist Anna Stary-Weinzinger from the Department of Pharmacology and Toxicology, University of Vienna investigated the opening and closing mechanisms of these channels: for the first time the full energy landscape of such a large protein ( 400 amino acids) could be calculated in atomic detail... Read More
Researchers Discover New Target For Personalized Cancer Therapy
May 07, 2013
A common cancer pathway causing tumor growth is now being targeted by a number of new cancer drugs and shows promising results. A team of researchers at Case Western Reserve University School of Medicine have developed a novel method to disrupt this growth signaling pathway, with findings that suggest a new treatment for breast, colon, melanoma and other cancers... Read More
Previous Page Next Page